Bone Biologics Corp balance sheet

At the end of fiscal 2020, Bone Biologics Corp had total assets of $0, total liabilities of $13.7m and shareholders' equity of −$13.7m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bone Biologics Corp: balance sheet, annual
Fiscal year	2016Dec 2016	2019Dec 2019	2020Dec 2020	LTMJun 2021
Cash and equivalents	1	0	—	0
Total current assets	1	0	—	—
Total assets	1	0	0	0
Accounts payable	0	0	0	—
Total current liabilities	2	1	14	—
Long-term debt	8	11	12	—
Total debt	9	11	12	12
Total liabilities	9	12	14	15
Shareholders' equity	−8	−12	−14	−15
Shares outstanding	—	—	37m	31m

US$ millions unless shown otherwise. Fiscal quarters.

Bone Biologics Corp: balance sheet, quarterly
Quarter	2018 Q4Dec 2018	2019 Q1Mar 2019	2020 Q1Mar 2020	2020 Q2Jun 2020	2020 Q3Sept 2020	2020 Q4Dec 2020	2021 Q1Mar 2021	2021 Q2Jun 2021
Total current assets	1	1	—	0	0	—	—	—
Total assets	1	1	0	—	—	0	0	0
Accounts payable	0	1	0	0	0	0	—	—
Total current liabilities	10	11	12	13	13	14	—	—
Long-term debt	9	10	11	12	12	12	—	—
Total debt	9	10	11	12	12	12	—	—
Total liabilities	10	—	12	13	13	14	14	15
Shareholders' equity	−9	−10	−12	−13	−13	−14	−14	−15
Shares outstanding	26m	28m	31m	31m	31m	12m	31m	31m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Bone Biologics Corp's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bone Biologics Corp.